You are here

A 'non-invasive' easy test for inflammatory bowel disease

Invention Number: 
13_2780
This invention will provide faster and accurate testing that can be performed by your local doctor.

The Invention

Inflammatory bowel disease is a life-long relapsing and remitting inflammatory disorder primarily affecting the gastrointestinal tract.

Invasive diagnostic investigations, specifically colonoscopy and histopathological evaluation, are the current standard for diagnosis.

This invention provides a method of diagnosing or assessing inflammatory bowel disease including Crohn’s disease and Ulcerative Colitis using a set of six protein/peptide markers by comparing the level of one or more markers relative to a reference value for the one or more markers.

The technology is also capable of distinguishing between Ulcerative Colitis and Crohn’s disease and the severity of the condition.

Key Benefits

The development of a point of care diagnostic test would provide:

  • Non-invasive testing
  • Rapid test and results
  • Accurate diagnosis
  • Significant reduction in medical costs
  • Faster intervention - better treatment options
  • Better disease management

The Opportunity

UNSW is seeking a commercial partner to licence and/or to work collaboratively with the inventor Dr Valerie Wasinger in the development of this diagnostic test.